Summary Although tissue polypeptide-specific antigen (TPS) has been described as a potentially useful serum marker of tumour activity in adult epithelial tumours, few data are available for childhood malignancies. Neuroblastomas and Wilms' tumours are the commonest types of solid malignancies found in the retroperitoneum of children. At The assay for tissue polypeptide-specific antigen (TPS) detects soluble fragments of cytokeratin 18 (Rydlander et al, 1996), an acid cytokeratin protein present in epithelial cells. Serum levels of TPS can be measured with an enzyme-linked immunosorbent assay (ELISA) that uses a high-affinity monoclonal antibody against M3, one of 35 identified epitopes of the tissue polypeptide antigen (TPA), which constitutes the specificity related to cell proliferation (Einarsson et al, 1997). TPS, as evaluated in cell culture supernatants, has been found to correlate with cell number and DNA synthesis rate (Madersbacher et al, 1993).Extensive studies have shown that TPS is useful in diagnosing and monitoring adult epithelial tumours of the breast (Einarsson, 1995;Bremer et al, 1996;Giai et al, 1996), lung (Pujol et al, 1994), prostate (Kramer et al, 1997) and gastrointestinal tract (Kornek et al, 1995). We have recently established normal values for paediatric patients (Rebhandl et al, 1997a), but few data are available as yet about TPS in paediatric malignancies. After cerebral malignancies, neuroblastoma and Wilms' tumour are the commonest solid tumours in childhood. They typically present as an upper abdominal mass.The aim of this study was to ascertain the role of TPS as a tumour marker for neuroblastoma and Wilms' tumour and determine its capability to discriminate between these two entities, as well as between benign and malignant tumours in general. (Rebhandl et al, 1997b); these samples were, therefore, excluded.We included 23 neuroblastomas (ten boys, 13 girls; mean age 2.2 years; range 2 weeks to 10.8 years), nine Wilms' tumours (four boys, five girls; mean age 3.7 years; range 7 weeks to 6.8 years) and 22 benign tumours (11 boys, 11 girls; mean age 2.3 years; range 2 weeks to 7.9 years) in the study.